Approach to the patient with acute severe autoimmune hepatitis

[1]  N. Chalasani,et al.  ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. , 2021, The American journal of gastroenterology.

[2]  J. Ehrmann,et al.  Acute onset of autoimmune hepatitis in children and adolescents. , 2020, Hepatobiliary & pancreatic diseases international : HBPD INT.

[3]  E. Shin,et al.  Autoimmune Hepatic Failure Following Acute Hepatitis A is Accompanied by Inflammatory Conversion of Regulatory T Cells , 2019, Yonsei medical journal.

[4]  X. Forns,et al.  Higher seroprevalence of hepatitis E virus in autoimmune hepatitis: Role of false‐positive antibodies , 2019, Liver international : official journal of the International Association for the Study of the Liver.

[5]  M. Manns,et al.  Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases , 2019, Hepatology.

[6]  Guiqiang Wang,et al.  The efficacy and safety of different doses of glucocorticoid for autoimmune hepatitis , 2019, Medicine.

[7]  M. Manns,et al.  Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune Hepatitis. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  Y. Chawla,et al.  Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update , 2019, Hepatology International.

[9]  T. Karlsen,et al.  EASL Clinical Practice Guidelines: Drug-induced liver injury. , 2019, Journal of hepatology.

[10]  A. Kazarine,et al.  Nonlinear microscopy of common histological stains reveals third harmonic generation harmonophores. , 2019, The Analyst.

[11]  S. Horslen,et al.  Corticosteroid Therapy for Indeterminate Pediatric Acute Liver Failure and Aplastic Anemia with Acute Hepatitis , 2019, The Journal of pediatrics.

[12]  Douglas C Macdonald,et al.  Autoimmune liver disease following acute hepatitis A infection , 2019, BMJ Case Reports.

[13]  N. Heaton,et al.  Acute Severe Autoimmune Hepatitis: Corticosteroids or Liver Transplantation? , 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[14]  M. Kumar,et al.  Flare of Autoimmune Hepatitis Causing Acute on Chronic Liver Failure: Diagnosis and Response to Corticosteroid Therapy , 2019, Hepatology.

[15]  J. Drenth,et al.  Association Between Black Race and Presentation and Liver-Related Outcomes of Patients With Autoimmune Hepatitis. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  M. Kudo,et al.  Liver damage related to immune checkpoint inhibitors , 2019, Hepatology International.

[17]  A. Montano‐Loza,et al.  Recurrent and De Novo Autoimmune Hepatitis , 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[18]  J. Iezzoni.  Diagnostic histochemistry in hepatic pathology. , 2018, Seminars in diagnostic pathology.

[19]  A. Tai,et al.  Correction: Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis , 2018, Clinical and Translational Gastroenterology.

[20]  G. Dalekos,et al.  Prompt initiation of high‐dose i.v. corticosteroids seems to prevent progression to liver failure in patients with original acute severe autoimmune hepatitis , 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

[21]  V. Caron,et al.  United states. , 2018, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[22]  G. Auzinger,et al.  Clinical and prognostic associations of liver volume determined by computed tomography in acute liver failure , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[23]  J. Trebicka,et al.  EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. , 2018, Journal of hepatology.

[24]  William M. Lee,et al.  Acute Liver Failure of Indeterminate Etiology: A Comprehensive Systematic Approach by An Expert Committee to Establish Causality , 2018, The American Journal of Gastroenterology.

[25]  F. Negro,et al.  EASL Clinical Practice Guidelines on hepatitis E virus infection. , 2018, Journal of hepatology.

[26]  A. Rosenberg,et al.  Hepatotoxicity of immune checkpoint inhibitors: An evolving picture of risk associated with a vital class of immunotherapy agents , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[27]  O. Yokosuka,et al.  Nationwide survey for acute liver failure and late-onset hepatic failure in Japan , 2018, Journal of Gastroenterology.

[28]  Molly F. Thomas,et al.  Diagnosis and Management of Hepatitis in Patients on Checkpoint Blockade , 2018, The oncologist.

[29]  A. Kahraman,et al.  Corticosteroid Therapy Improves the Outcome of Autoimmune Hepatitis-Induced Acute Liver Failure , 2018, Digestion.

[30]  A. Kahraman,et al.  Potential triggering factors of acute liver failure as a first manifestation of autoimmune hepatitis-a single center experience of 52 adult patients , 2018, World journal of gastroenterology.

[31]  P. Brennan,et al.  Systematic review: non A‐E, seronegative or indeterminate hepatitis; what is this deadly disease? , 2018, Alimentary pharmacology & therapeutics.

[32]  Tinghong Ye,et al.  Clinical and Pathological Characteristics of Autoimmune Hepatitis with Acute Presentation , 2018, Canadian journal of gastroenterology & hepatology.

[33]  M. Yeh,et al.  Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury , 2018, Modern Pathology.

[34]  Lanjuan Li,et al.  Bacterial Infection and Predictors of Mortality in Patients with Autoimmune Liver Disease-Associated Acute-On-Chronic Liver Failure , 2018, Canadian journal of gastroenterology & hepatology.

[35]  T. Krech,et al.  Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis. , 2017, Journal of hepatology.

[36]  T. Kav,et al.  Treatment Response and Outcome with Two Different Prednisolone Regimens in Autoimmune Hepatitis , 2017, Digestive Diseases and Sciences.

[37]  Jianxing He,et al.  Risk of hepatotoxicity in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta‐analysis of published data , 2017, International journal of cancer.

[38]  P. Kamath,et al.  Hepatotoxicity After Immune Checkpoint Inhibitor Therapy in Melanoma: Natural Progression and Management , 2017, American journal of clinical oncology.

[39]  P. Rathi,et al.  Natural History and Treatment Outcomes of Severe Autoimmune Hepatitis , 2017, Journal of clinical gastroenterology.

[40]  M. Manns,et al.  EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. , 2017, Journal of hepatology.

[41]  K. Tsuneyama,et al.  Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients , 2017, Journal of Clinical Pathology.

[42]  Samar Kamal Darweesh,et al.  Effect of N-Acetylcysteine on Mortality and Liver Transplantation Rate in Non-Acetaminophen-Induced Acute Liver Failure: A Multicenter Study , 2017, Clinical Drug Investigation.

[43]  A. Montano‐Loza,et al.  Systematic review: recurrent autoimmune liver diseases after liver transplantation , 2017, Alimentary pharmacology & therapeutics.

[44]  S. Kakar,et al.  Autoimmune hepatitis: review of histologic features included in the simplified criteria proposed by the international autoimmune hepatitis group and proposal for new histologic criteria , 2017, Modern Pathology.

[45]  O. Yokosuka,et al.  Infectious complications, steroid use and timing for emergency liver transplantation in acute liver failure: analysis in a Japanese center , 2016, Journal of hepato-biliary-pancreatic sciences.

[46]  T. Baumert,et al.  Usefulness of corticosteroids as first-line therapy in patients with acute severe autoimmune hepatitis. , 2016, Journal of hepatology.

[47]  O. Yokosuka,et al.  Analysis of infectious complications and timing for emergency liver transplantation in autoimmune acute liver failure , 2016, Journal of hepato-biliary-pancreatic sciences.

[48]  William M. Lee,et al.  Determinants of outcome among patients with acute liver failure listed for liver transplantation in the United States , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[49]  J. Neuberger,et al.  Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[50]  D. Tiniakos,et al.  Role of Histopathology in Autoimmune Hepatitis , 2015, Digestive Diseases.

[51]  O. Yokosuka,et al.  Severe and fulminant hepatitis of indeterminate etiology in a Japanese center , 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

[52]  D. Samuel,et al.  The role of corticosteroids in acute-severe autoimmune hepatitis is still highly debatable. , 2015, Journal of hepatology.

[53]  M. Sira,et al.  Serological markers of autoimmunity in children with hepatitis A: relation to acute and fulminant presentation , 2015, European journal of gastroenterology & hepatology.

[54]  Jinhua Hu,et al.  Efficacy and safety of acetylcysteine in "non-acetaminophen" acute liver failure: A meta-analysis of prospective clinical trials. , 2015, Clinics and research in hepatology and gastroenterology.

[55]  Amitabh Srivastava,et al.  Ipilimumab-associated Hepatitis: Clinicopathologic Characterization in a Series of 11 Cases , 2015, The American journal of surgical pathology.

[56]  M. Mendizabal,et al.  Fulminant presentation of autoimmune hepatitis: clinical features and early predictors of corticosteroid treatment failure , 2015, European journal of gastroenterology & hepatology.

[57]  T. Hibi,et al.  Pregnant woman with non‐comatose autoimmune acute liver failure in the second trimester rescued using medical therapy: A case report , 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

[58]  L. D’Antiga,et al.  Fulminant Hepatic Failure of Autoimmune Aetiology in Children , 2015, Journal of pediatric gastroenterology and nutrition.

[59]  R. Andrade,et al.  Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease. , 2014, World journal of hepatology.

[60]  William M. Lee,et al.  Steroid use in acute liver failure , 2014, Hepatology.

[61]  T. Himoto,et al.  Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis , 2013, Autoimmunity Highlights.

[62]  William M. Lee,et al.  Improvements in Hepatic Serological Biomarkers Are Associated with Clinical Benefit of Intravenous N-Acetylcysteine in Early Stage Non-Acetaminophen Acute Liver Failure , 2013, Digestive Diseases and Sciences.

[63]  P. Kamath,et al.  Acute-on chronic liver failure. , 2012, Journal of hepatology.

[64]  K. Abe,et al.  Centrilobular necrosis in acute presentation of Japanese patients with type 1 autoimmune hepatitis. , 2012, World journal of hepatology.

[65]  V. Nobili,et al.  Autoimmune hepatitis in children: an overview of the disease focusing on current therapies , 2012, European journal of gastroenterology & hepatology.

[66]  A. Czaja.  Diagnosis, Pathogenesis, and Treatment of Autoimmune Hepatitis After Liver Transplantation , 2012, Digestive Diseases and Sciences.

[67]  D. Kleiner,et al.  Pathologic Changes in Ipilimumab-Related Hepatitis in Patients with Metastatic Melanoma , 2012, Digestive Diseases and Sciences.

[68]  William M. Lee,et al.  Introduction to the Revised American Association for the Study of Liver Diseases Position Paper on Acute Liver Failure 2011 , 2012, Hepatology.

[69]  D. D'Agostino,et al.  Pediatric End-stage Liver Disease Score in Acute Liver Failure to Assess Poor Prognosis , 2012, Journal of pediatric gastroenterology and nutrition.

[70]  O. Yokosuka,et al.  Importance of computed tomography imaging features for the diagnosis of autoimmune acute liver failure , 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

[71]  D. Vergani,et al.  Autoimmune liver diseases in children - what is different from adulthood? , 2011, Best practice & research. Clinical gastroenterology.

[72]  C. Schramm,et al.  Drug induced liver injury and its relationship to autoimmune hepatitis. , 2011, Journal of hepatology.

[73]  R. Andrade,et al.  The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug‐induced liver injury , 2011, Hepatology.

[74]  O. Yokosuka,et al.  Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group criteria in acute‐onset autoimmune hepatitis , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[75]  B. Portmann,et al.  Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis , 2011, Hepatology.

[76]  O. Yokosuka,et al.  Clinicopathological features of severe and fulminant forms of autoimmune hepatitis , 2011, Journal of Gastroenterology.

[77]  William M. Lee,et al.  Autoimmune acute liver failure: Proposed clinical and histological criteria , 2011, Hepatology.

[78]  O. Yokosuka,et al.  Autoimmune fulminant liver failure in adults: Experience in a Japanese center , 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

[79]  A. Czaja.  Performance Parameters of the Conventional Serological Markers for Autoimmune Hepatitis , 2011, Digestive Diseases and Sciences.

[80]  M. Manns,et al.  Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. , 2010, Gastroenterology.

[81]  Y. Zen,et al.  Prognosis of acute severe autoimmune hepatitis (AS-AIH): the role of corticosteroids in modifying outcome. , 2010, Journal of hepatology.

[82]  K. Mehmood,et al.  Risk factors for fulminant hepatic failure and their relation with outcome in children. , 2010, JPMA. The Journal of the Pakistan Medical Association.

[83]  P. Tandon,et al.  Risk factors for recurrence of autoimmune hepatitis after liver transplantation , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[84]  William M. Lee,et al.  Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. , 2009, Gastroenterology.

[85]  M. Vyberg,et al.  Detection of early zone 3 liver fibrosis in chronic alcoholics. A comparison of four connective tissue staining methods. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology.

[86]  B. Portmann,et al.  Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease , 2009, Hepatology.

[87]  Anurag Maheshwari,et al.  Liver failure as initial presentation of autoimmune hepatitis: Clinical characteristics, predictors of response to steroid therapy, and outcomes , 2009, Hepatology.

[88]  Y. Chawla,et al.  Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014 , 2009, Hepatology International.

[89]  O. Yokosuka,et al.  Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute-onset autoimmune hepatitis , 2008, Journal of Gastroenterology.

[90]  Y. Takikawa,et al.  Clinical epidemiology of fulminant hepatitis in Japan , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

[91]  J. Trotter,et al.  Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[92]  K. Boberg,et al.  AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Simplified Criteria for the Diagnosis of Autoimmune Hepatitis , 2008 .

[93]  Y. Maehara,et al.  Living donor liver transplantation for acute liver failure: a 10-year experience in a single center. , 2008, Journal of the American College of Surgeons.

[94]  M. Torbenson,et al.  The impact of ethnicity on the natural history of autoimmune hepatitis , 2007, Hepatology.

[95]  D. Vergani,et al.  The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study. , 2007, Journal of hepatology.

[96]  A. Montano‐Loza,et al.  Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end‐stage liver disease , 2007, Hepatology.

[97]  Y. Shiratori,et al.  Clinical features of Japanese type 1 autoimmune hepatitis patients with zone III necrosis , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[98]  D. Samuel,et al.  Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[99]  L. Ferrell,et al.  Special stains can distinguish hepatic necrosis with regenerative nodules from cirrhosis , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[100]  A. Abdo,et al.  Liver transplantation for autoimmune hepatitis: a single-center experience. , 2007, Transplantation proceedings.

[101]  Y. Hiasa,et al.  Clinicopathologic features of the severe form of acute type 1 autoimmune hepatitis. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[102]  J. Lefkowitch.  Special stains in diagnostic liver pathology. , 2006, Seminars in diagnostic pathology.

[103]  Y. Miyake,et al.  Clinical characteristics of fulminant‐type autoimmune hepatitis: an analysis of eleven cases , 2006, Alimentary pharmacology & therapeutics.

[104]  E. Penner,et al.  Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation , 2006, Journal of Clinical Pathology.

[105]  M. Taniai,et al.  Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful? , 2005, Journal of Gastroenterology.

[106]  M. Ichinose,et al.  Autoimmune hepatitis triggered by acute hepatitis A. , 2005, World journal of gastroenterology.

[107]  D. Kelly,et al.  Etiology, Outcome and Prognostic Indicators of Childhood Fulminant Hepatic Failure in the United Kingdom , 2005, Journal of pediatric gastroenterology and nutrition.

[108]  T. Sauerbruch,et al.  Autoimmune Hepatitis – Sequel of a Relapsing Hepatitis A in a 75-Year-Old Woman , 2005, Digestion.

[109]  O. Cummings,et al.  Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[110]  K. Lindor,et al.  The Prevalence of Autoantibodies and Autoimmune Hepatitis in Patients with Nonalcoholic Fatty Liver Disease , 2004, American Journal of Gastroenterology.

[111]  J. Misdraji,et al.  Autoimmune Hepatitis With Centrilobular Necrosis , 2004, The American journal of surgical pathology.

[112]  S. Aydoğdu,et al.  Our experience with fulminant hepatic failure in Turkish children: etiology and outcome. , 2003, Journal of tropical pediatrics.

[113]  A. Lonardo,et al.  Non-Organ-Specific Autoantibodies in Nonalcoholic Fatty Liver Disease: Prevalence and Correlates , 2003, Digestive Diseases and Sciences.

[114]  J. Calleja,et al.  Liver transplantation for autoimmune hepatitis: fulminant versus chronic hepatitis presentation. , 2003, Transplantation proceedings.

[115]  Kazuhide Yamamoto,et al.  Clinicopathological features of acute-onset autoimmune hepatitis. , 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

[116]  G. Farr,et al.  Acute autoimmune hepatitis presenting with centrizonal liver disease: case report and review of the literature , 2002, American Journal of Gastroenterology.

[117]  B. McMahon,et al.  Prevalence of autoimmune liver disease in Alaska natives , 2002, American Journal of Gastroenterology.

[118]  P. Donaldson,et al.  Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States. , 2002, Journal of hepatology.

[119]  M. Zelazko,et al.  Protracted, but not acute, hepatitis A virus infection is strongly associated with HLA‐DRB1*1301, a marker for pediatric autoimmune hepatitis , 2001, Hepatology.

[120]  G. Gerken,et al.  Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience. , 2001, Zeitschrift fur Gastroenterologie.

[121]  M. Schwartz,et al.  Liver transplantation for autoimmune hepatitis , 2000, Hepatology.

[122]  J. Pomposelli,et al.  Liver transplantation for autoimmune hepatitis: A long‐term pathologic study , 2000, Hepatology.

[123]  P. Donaldson,et al.  Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis. , 1999, Gastroenterology.

[124]  Y. Liaw,et al.  Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failure , 1999, Journal of gastroenterology and hepatology.

[125]  D. Vergani,et al.  De-novo autoimmune hepatitis after liver transplantation , 1998, The Lancet.

[126]  D. Vergani,et al.  Autoimmune hepatitis in childhood: A 20‐year experience , 1997, Hepatology.

[127]  K. Meyer zum Büschenfelde,et al.  Autoimmune hepatitis following hepatitis A virus infection. , 1995, Journal of hepatology.

[128]  Roger Williams,et al.  Acute liver failure: redefining the syndromes , 1993, The Lancet.

[129]  E. Concia,et al.  Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals , 1991, The Lancet.

[130]  F. Alvarez,et al.  Anti-liver-kidney microsome antibody-positive autoimmune hepatitis presenting as fulminant liver failure. , 1990, Journal of pediatric gastroenterology and nutrition.

[131]  F. Alvarez,et al.  Autoimmune hepatitis with initial presentation as acute hepatic failure in young children. , 1990, The Journal of pediatrics.

[132]  T. Laskus,et al.  Autoimmune chronic active hepatitis developing after acute type B hepatitis , 1989, Digestive Diseases and Sciences.

[133]  J. Ludwig,et al.  Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis. , 1988, Gastroenterology.

[134]  R. Wright,et al.  PERSISTENT MEASLES VIRUS GENOME IN AUTOIMMUNE CHRONIC ACTIVE HEPATITIS , 1987, The Lancet.

[135]  P. Scheuer,et al.  Hepatic fibrosis and collapse: histological distinction by orcein staining , 1980, Histopathology.

[136]  S. Pocock,et al.  Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis. , 1980, Gut.

[137]  W. Summerskill,et al.  Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. , 1975, Gut.

[138]  D. Samuel,et al.  Liver injury from cancer immunotherapy using monoclonal immune checkpoint inhibitors , 2018 .

[139]  M. Rudler,et al.  Treatment and prognosis of acute severe autoimmune hepatitis , 2017 .

[140]  H. Isoniemi,et al.  High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial. , 2016, Journal of hepatology.

[141]  N. Kerkar,et al.  'De novo' and 'recurrent' autoimmune hepatitis after liver transplantation: A comprehensive review. , 2016, Journal of autoimmunity.

[142]  J. Drenth.  EASL Clinical Practice Guidelines: Autoimmune hepatitis. , 2015, Journal of hepatology.

[143]  A. Abu-Hanna,et al.  UvA-DARE ( Digital Academic Repository ) Acute liver failure and acute kidney injury : Definitions , prognosis , and outcome , 2013 .

[144]  V. Navarro,et al.  Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[145]  D. Vergani,et al.  Autoimmune hepatitis. , 2009, Journal of pediatric gastroenterology and nutrition.

[146]  K. Abe,et al.  A Recovery Case of Acute-Onset Autoimmune Hepatitis Presenting as Fulminant Hepatic Ffailure, Who Received Living Donor-Liver Transplantion , 2006 .

[147]  J. Farrell,et al.  The Management of Fulminant Hepatic Failure , 2001 .